NDC 70121-1570 – Releuko

Filgrastim 480 ug/.8mL · Injection, Solution · Intravenous, Subcutaneous

Human Prescription Drug

Product NDC70121-1570

Product details

Brand name
Releuko
Generic name
Filgrastim
Labeler
Amneal Pharmaceuticals LLC
Dosage form
Injection, Solution
Route
Intravenous, Subcutaneous
Marketing category
BLA · BLA761082
Marketed since
February 25, 2022
Listing expires
December 31, 2026
Pharmacologic class
Leukocyte Growth Factor

Active ingredients

Uses, dosage, side effects and warnings for Releuko →

Package NDC codes (2)

Package NDCDescriptionSince
70121-1570-11 SYRINGE in 1 BOX (70121-1570-1) / .8 mL in 1 SYRINGEFeb 25, 2022
70121-1570-710 SYRINGE in 1 BOX (70121-1570-7) / .8 mL in 1 SYRINGEFeb 25, 2022

Other Releuko products